retatrutide trial results news First phase 3 data, a Triumph of Science! Retatrutide Weight Loss Results:Trial Data

For those who used an alternative as-treated definition for drug use, the analysis found a median follow-up time of 1.8 years with 90-day gap and tail periods (HR, 1.37

Key takeaways Retatrutide isn't approved yet and isn't expected to launch in the UK until at least mid-2026 In clinical trials, target doses ranged from 0.5mg to 12mg weekly, with the most common being 4mg, 8mg, 9mg and 12mg Different dosing schedules were tested, with most people starting at 2mg and escalating every 4 weeks The 12mg dose produced the most weight loss (up to 28.7% after 68 weeks) Starting at 2mg rather than 4mg helped reduce side effects during escalation First to know Get an email the day retatrutide launches in the UK

Always carry fast acting carbohydrqates during training

Thanks!